Molecular Partners Ag (MOLN) Return on Assets (2021 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Return on Assets of 14.62% for Q1 2026, down 1462.0% year-on-year from 1.07% in Q1 2025, and down 25.21% on a QoQ basis from 11.67% in Q4 2025.

Molecular Partners Ag (MOLN) Return on Assets (2021 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Return on Assets for 6 consecutive years, with 14.62% the latest figure, recorded in Q1 2026.

  • Quarterly Return on Assets fell 1462.0% year-over-year to 14.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.62% (down 1462.0% YoY) and the FY2025 annual result came in at 0.01%, down 1.0% from the prior year.
  • Return on Assets retreated to 14.62% in Q1 2026 per MOLN's latest filing, from 11.67% in the prior quarter.
  • Over the last five years, Return on Assets for MOLN reached as high as 0.0% in Q1 2023 and fell as low as 14.62% in Q1 2026.
  • A 5-year average of 2.07% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
  • Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2026, when it tumbled 1462 bps.
  • Year by year, Return on Assets stood at 0.0% in 2022, then tumbled by 186 bps to 0.0% in 2023, then rose by 4 bps to 0.0% in 2024, then plunged by 167027647 bps to 11.67% in 2025, then retreated by 25 bps to 14.62% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods registered 14.62%, 11.67%, and 8.87% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.69%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -0.01%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -0.80%
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 0.00%
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -14.62%

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.62%
Dec 31, 2025 -11.67%
Sep 30, 2025 -8.87%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%